Xilio Therapeutics Inc.

NASDAQ: XLO · Real-Time Price · USD
0.70
-0.00 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
0.70
-0.74%
After-hours: Aug 15, 2025, 06:54 PM EDT

Xilio Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-58.24M -76.4M -88.22M -75.8M
Depreciation & Amortization
1.64M 1.9M 1.85M 1.5M
Stock-Based Compensation
6.43M 7.38M 8.42M 4.96M
Other Working Capital
30.26M 2.47M 1.52M -8.98M
Other Non-Cash Items
3K -3.97M 224K 173K
Deferred Income Tax
n/a 2.06M n/a 222K
Change in Working Capital
31.78M 405K 2M -11.8M
Operating Cash Flow
-18.38M -68.62M -75.72M -80.75M
Capital Expenditures
-36K -486K -1.87M -1.1M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-36K -486K -1.87M -1.1M
Debt Repayment
-3.38M -6.75M -85K -110K
Common Stock Repurchased
n/a 194K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
25.75M 202K 16K -467K
Financial Cash Flow
29.2M -6.55M -69K 260.67M
Net Cash Flow
10.78M -75.66M -77.66M 178.82M
Free Cash Flow
-18.41M -69.11K -77.59M -81.85M